761 vs AXNA: Side-by-Side Comparison
Compare PHARMANUTRA S.P.A. (761) and Amplifon S.p.A (AXNA) side by side: market cap EUR 822.51M vs EUR 2.62B, P/E 39.0 vs 31.8. Financials, growth and model signals on Bullrun.
| Metric | 761 | AXNA |
|---|---|---|
| Company | PHARMANUTRA S.P.A. | Amplifon S.p.A |
| Country / Exchange | Italy · F | Italy · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Medical Distribution |
| Market cap | EUR 822.51M | EUR 2.62B |
| P/E ratio | 39.0 | 31.8 |
| Dividend yield | 1.40% | 2.94% |
| Valuation model | 0.9% undervalued | 28.1% overvalued |
| Revenue (FY2025) | EUR 131.69M | EUR 2.40B |
| Revenue growth YoY | +14.0% | -0.6% |
| Net income | EUR 20.00M | EUR 91.55M |
| Gross margin | — | — |
| Diluted EPS | 2090.00 | 0.40 |